Literature DB >> 20956406

Prevalence of cardiovascular diseases in psoriatic arthritis resembles that of rheumatoid arthritis.

A Jamnitski, I M Visman, M J L Peters, M Boers, B A C Dijkmans, M T Nurmohamed.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20956406     DOI： 10.1136/ard.2010.136499

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  15 in total

Review 1.  [Psoriatic arthritis : a permanent challenge for rheumatologists and patients--Part 1: epidemiology, pathogenesis and clinical course].

Authors:  S Finzel; M Englbrecht
Journal:  Z Rheumatol       Date:  2011-10       Impact factor: 1.372

2.  Higher rates and clustering of abnormal lipids, obesity, and diabetes mellitus in psoriatic arthritis compared with rheumatoid arthritis.

Authors:  Monalyn Labitigan; Asena Bahče-Altuntas; Joel M Kremer; George Reed; Jeff D Greenberg; Nicole Jordan; Chaim Putterman; Anna Broder
Journal:  Arthritis Care Res (Hoboken)       Date:  2014-04       Impact factor: 4.794

3.  Cardiovascular risk in psoriatic arthritis - a cross-sectional study.

Authors:  Claudiu Popescu; Ana Maria Pintilie; Violeta Bojinca; Andra Balanescu; Ruxandra Ionescu
Journal:  Maedica (Buchar)       Date:  2014-03

4.  Cardiovascular risk in patients with psoriatic arthritis.

Authors:  Tracy Y Zhu; Edmund K Li; Lai-Shan Tam
Journal:  Int J Rheumatol       Date:  2012-05-08

5.  Cardiovascular disease in immune-mediated inflammatory diseases: A cross-sectional analysis of 6 cohorts.

Authors:  Benjamín Fernández-Gutiérrez; Pedro P Perrotti; Javier P Gisbert; Eugeni Domènech; Antonio Fernández-Nebro; Juan D Cañete; Carlos Ferrándiz; Jesús Tornero; Valle García-Sánchez; Julián Panés; Eduardo Fonseca; Francisco Blanco; Jesús Rodríguez-Moreno; Patricia Carreira; Antonio Julià; Sara Marsal; Luis Rodriguez-Rodriguez
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

Review 6.  Systemic Inflammatory Response and Atherosclerosis: The Paradigm of Chronic Inflammatory Rheumatic Diseases.

Authors:  Aikaterini Arida; Athanasios D Protogerou; George D Kitas; Petros P Sfikakis
Journal:  Int J Mol Sci       Date:  2018-06-27       Impact factor: 5.923

7.  Changes in Lipid Levels and Incidence of Cardiovascular Events Following Tofacitinib Treatment in Patients With Psoriatic Arthritis: A Pooled Analysis Across Phase III and Long-Term Extension Studies.

Authors:  Dafna D Gladman; Christina Charles-Schoeman; Iain B McInnes; Douglas J Veale; Bruce Thiers; Mike Nurmohamed; Dani Graham; Cunshan Wang; Thomas Jones; Robert Wolk; Ryan DeMasi
Journal:  Arthritis Care Res (Hoboken)       Date:  2019-10       Impact factor: 4.794

8.  Higher depression rates and similar cardiovascular comorbidity in psoriatic arthritis compared with rheumatoid arthritis and diabetes mellitus.

Authors:  George E Fragoulis; Gerasimos Evangelatos; Nikolaos Tentolouris; Kalliopi Fragkiadaki; Stylianos Panopoulos; George Konstantonis; Alexios Iliopoulos; Katerina Chatzidionysiou; Petros P Sfikakis; Maria G Tektonidou
Journal:  Ther Adv Musculoskelet Dis       Date:  2020-12-08       Impact factor: 5.346

Review 9.  Impact of body weight on the achievement of minimal disease activity in patients with rheumatic diseases: a systematic review and meta-analysis.

Authors:  Roberta Lupoli; Paolo Pizzicato; Antonella Scalera; Pasquale Ambrosino; Manuela Amato; Rosario Peluso; Matteo Nicola Dario Di Minno
Journal:  Arthritis Res Ther       Date:  2016-12-13       Impact factor: 5.156

10.  Cardiovascular disease risk assessment in patients with familial Mediterranean fever related renal amyloidosis.

Authors:  Micol Romano; David Piskin; Roberta A Berard; Bradley C Jackson; Cengizhan Acikel; Juan J Carrero; Helen J Lachmann; Mahmut I Yilmaz; Erkan Demirkaya
Journal:  Sci Rep       Date:  2020-10-27       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.